2012-10-06 19:28:05 - New Pharmaceuticals market report from Global Markets Direct: "Yuhan Corporation - Product Pipeline Review - 2012"

Global Market Direct's pharmaceuticals report, "Yuhan Corporation - Product Pipeline Review - 2012" provides data on the Yuhan Corporation's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Yuhan Corporation's corporate website, SEC filings, investor presentations and featured press releases, both from Yuhan Corporation and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Yuhan Corporation - Brief Yuhan Corporation overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of Yuhan Corporation human therapeutic division.
*

Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Yuhan Corporation with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Yuhan Corporation's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/468620_yuhan_corporation_product_pipeline_re ..


Reasons to buy

* Evaluate Yuhan Corporation's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Yuhan Corporation in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Yuhan Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Yuhan Corporation.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Yuhan Corporation and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Yuhan Corporation Snapshot
Yuhan Corporation Overview
Key Information
Key Facts
Yuhan Corporation - Research and Development Overview
Key Therapeutic Areas
Yuhan Corporation - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Yuhan Corporation - Pipeline Products Glance
Yuhan Corporation - Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Yuhan Corporation Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Yuhan Corporation - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Yuhan Corporation - Drug Profiles
2nd Generation APA
Product Description
Mechanism of Action
R&D Progress
Anti Hypertensive Agent
Product Description
Mechanism of Action
R&D Progress
Anti-Diabetic GKA
Product Description
Mechanism of Action
R&D Progress
Anti-RA
Product Description
Mechanism of Action
R&D Progress
bilastine
Product Description
Mechanism of Action
R&D Progress
Drug For Cancer
Product Description
Mechanism of Action
R&D Progress
Drug For Diabetes
Product Description
Mechanism of Action
R&D Progress
Drug Targeting PPAR
Product Description
Mechanism of Action
R&D Progress
HL040
Product Description
Mechanism of Action
R&D Progress
YH-12852
Product Description
Mechanism of Action
R&D Progress
YH-12852
Product Description
Mechanism of Action
R&D Progress
YH-14617
Product Description
Mechanism of Action
R&D Progress
YH-14618
Product Description
Mechanism of Action
R&D Progress
YH-14810
Product Description
Mechanism of Action
R&D Progress
YH-4808
Product Description
Mechanism of Action
R&D Progress
YH_Bio2
Product Description
Mechanism of Action
R&D Progress
YH_Chem2
Product Description
Mechanism of Action
R&D Progress
YH14642
Product Description
Mechanism of Action
R&D Progress
YHB1411-2
Product Description
Mechanism of Action
R&D Progress
YHD-001
Product Description
Mechanism of Action
R&D Progress
YHD-1023
Product Description
Mechanism of Action
R&D Progress
Yuhan Corporation - Pipeline Analysis
Yuhan Corporation - Pipeline Products by Therapeutic Class
Yuhan Corporation - Pipeline Products by Route of Administration
Yuhan Corporation - Pipeline Products By Mechanism of Action
Yuhan Corporation - Recent Pipeline Updates
Yuhan Corporation - Company Statement
Yuhan Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Yuhan Corporation - Key Manufacturing Facilities
Financial Deals Landscape
Yuhan Corporation, Deals Summary
Yuhan Corporation, Pharmaceuticals & Healthcare, Deal Details
Partnerships
Yuhan Enters Into Co-Development Agreement With Seikagaku Biobusiness
Yuhan Enters Into Co-Development Agreement With Ensoltek

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468620&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.